Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00041166) titled 'Prospective Response Investigation by Multimodal Evaluation after Neoadjuvant Systemic Therapy prior to Radical Cystectomy (PRIME-RC)' on Sept. 1.

Study Type: observational

Study Design: Allocation: Masking: Control: Assignment: Study design purpose: diagnostic

Primary Sponsor: Universitatsklinikum Hamburg-Eppendorf (UKE)

Condition: C67 Malignant neoplasm of bladder

Intervention: Group 1: Patients with histologically confirmed muscle-invasive bladder cancer (MIBC) after neoadjuvant systemic therapy and planned radical cystectomy. A standardized preoperative cystoscopy with urine cytology and cold biopsy (PE) ...